Nasdaq
ELVN
Enliven Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +1.0%
- 1 month
- +18.4%
- 1 year
- +220%
$60.27 · Mkt cap $3.67B
At the 6 Aug 2026 close
Nasdaq
Enliven Therapeutics, Inc.
$60.27 · Mkt cap $3.67B
At the 6 Aug 2026 close
Enliven Therapeutics, Inc. trades under the ticker ELVN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $3.67B. The last closing price was $60.27, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +220%, and +18.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ELVN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.